BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8372817)

  • 1. Observation of serum estradiol testosterone and immune function in aplastic anemia.
    Cao Q; Liu J
    Am J Hematol; 1993 Aug; 43(4):322-3. PubMed ID: 8372817
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocyte migration-inhibitory activity in serum from patients with aplastic anemia.
    Fassas A; Bruley-Rosset M
    N Engl J Med; 1979 Jan; 300(2):91-2. PubMed ID: 758585
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic function in aplastic anemia.
    Gale RP; Mitsuyasu R; Yale C
    Haematol Blood Transfus; 1979; 24():229-36. PubMed ID: 540795
    [No Abstract]   [Full Text] [Related]  

  • 4. Depression of natural killer cell activity in patients with aplastic anemia.
    Yagita M; Sugiyama H; Takahashi T; Imura H; Iho S; Hoshino T; Uchida A
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):893-903. PubMed ID: 4060983
    [No Abstract]   [Full Text] [Related]  

  • 5. [Natural killer activity of peripheral blood in patients with aplastic anemia].
    Zhang RF; Ni NS; Yang HZ
    Zhonghua Nei Ke Za Zhi; 1986 Jun; 25(6):350-2, 382. PubMed ID: 3757623
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic defects in young male patients with hepatitis-associated aplastic anemia.
    Foon KA; Mitsuyasu RT; Schroff RW; McIntyre RE; Champlin R; Gale RP
    Ann Intern Med; 1984 May; 100(5):657-62. PubMed ID: 6608893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased interleukin-1 production in aplastic anemia.
    Gascon P; Scala G
    Am J Med; 1988 Nov; 85(5):668-74. PubMed ID: 3263800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The lymphocytes of the patients with hypoplastic anemia (author's transl)].
    Arimori S; Kobashi H; Tada S; Ichikawa Y; Koriyama K
    Rinsho Ketsueki; 1975 Aug; 16(8):763-7. PubMed ID: 1237637
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phytohemagglutinin stimulation of lymphocytes in patients with aplastic anemia].
    Haas RJ; Kretschmer V; Fliedner TM
    Med Klin; 1970 Apr; 65(15):724-9. PubMed ID: 5522792
    [No Abstract]   [Full Text] [Related]  

  • 10. Some immunological studies in aplastic anaemia.
    Falcão RP; Voltarelli JC; Bottura C
    J Clin Lab Immunol; 1983 Jan; 10(1):25-8. PubMed ID: 6600793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory activity of T cells on hematopoiesis and gamma-IFN production by T cells from peripheral blood in patients with aplastic anemia].
    Hanada T; Yamamura H; Ehara T; Nakahara S; Shibuya A; Abe T; Takita H
    Nihon Ketsueki Gakkai Zasshi; 1988 May; 51(3):571-5. PubMed ID: 3138870
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory factors to hematopoiesis in aplastic anemia and pure red cell aplasia.
    Hanada T; Abe T
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1572-80. PubMed ID: 3150203
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia.
    Hoffman R; Zanjani ED; Lutton JD; Zalusky R; Wasserman LR
    N Engl J Med; 1977 Jan; 296(1):10-3. PubMed ID: 830263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum erythropoietin levels and bone marrow hematopoiesis in patients with aplastic anemia].
    Ogawa T
    Rinsho Ketsueki; 1996 Jul; 37(7):604-9. PubMed ID: 8779780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic mechanisms in aplastic anemia.
    Finlay JL; Ershler WB; Shahidi NT
    Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia.
    Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z
    Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres.
    Bär C; Huber N; Beier F; Blasco MA
    Haematologica; 2015 Oct; 100(10):1267-74. PubMed ID: 26206796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1*15 and pediatric aplastic anemia.
    Oguz FS; Yalman N; Diler AS; Oguz R; Anak S; Dorak MT
    Haematologica; 2002 Jul; 87(7):772-4. PubMed ID: 12091130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia.
    Brooks BJ; Broxmeyer HE; Bryan CF; Leech SH
    Arch Intern Med; 1984 Jul; 144(7):1474-7. PubMed ID: 6732407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in peripheral blood of children with aplastic anaemia].
    Huang YL; Huang SL; Fang JP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):794-5. PubMed ID: 17229390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.